{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:39:40Z","timestamp":1785386380886,"version":"3.55.0"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1248\/bpb.b20-00314","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T22:13:21Z","timestamp":1601504001000},"page":"1519-1525","source":"Crossref","is-referenced-by-count":13,"title":["Prescription of Colchicine with Other Dangerous Concomitant Medications: A Nation-Wide Survey Using the Japanese Claims Database"],"prefix":"10.1248","volume":"43","author":[{"given":"Shungo","family":"Imai","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Momo","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmaceutics, School of Pharmacy, Showa University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Miyai","sequence":"additional","affiliation":[{"name":"Graduate School of Life Science, Hokkaido University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Hokkaido University"},{"name":"Department of Pharmacy, Hokkaido University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Takekuma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hokkaido University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am. J. Med.<\/i>, 128<\/b>, 461\u2013470 (2015)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hatemi G, Christensen R, Bang D, et al.<\/i> 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann. Rheum. Dis.<\/i>, 77<\/b>, 808\u2013818 (2018).","DOI":"10.1136\/annrheumdis-2018-213225"},{"key":"3","unstructured":"3) Robinson KP, Chan JJ. Colchicine in dermatology: a review. Australas. J. Dermatol.<\/i>, 59<\/b>, 278\u2013285 (2018)."},{"key":"4","unstructured":"4) Putterman C, Ben-Chetrit E, Caraco Y, Levy M. Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin. Arthritis Rheum.<\/i>, 21<\/b>, 143\u2013155 (1991)."},{"key":"5","unstructured":"5) Hung IF, Wu AK, Cheng VC, Tang BS, To KW, Yeung CK, Woo PC, Lau SK, Cheung BM, Yuen KY. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin. Infect. Dis.<\/i>, 41<\/b>, 291\u2013300 (2005)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Cheng VC, Ho PL, Yuen KY. Two probable cases of serious drug interaction between clarithromycin and colchicine. South. Med. J.<\/i>, 98<\/b>, 811\u2013813 (2005).","DOI":"10.1097\/01.SMJ.0000163315.02563.B2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Eleftheriou G, Bacis G, Fiocchi R, Sebastiano R. Colchicine-induced toxicity in a heart transplant patient with chronic renal failure. Clin. Toxicol.<\/i> (Phila), 46<\/b>, 827\u2013830 (2008).","DOI":"10.1080\/15563650701779703"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Beaudreuil S, Schermann JM, Verstuyft C, Barrail-Tran A, Smirnova M, Durrbach A, Becquemont L. Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients. Clin. Transplant.<\/i>, 32<\/b>, e13405 (2018).","DOI":"10.1111\/ctr.13405"},{"key":"9","unstructured":"9) Yousuf Bhat Z, Reddy S, Pillai U, Doshi M, Wilpula E. Colchicine-induced myopathy in a tacrolimus-treated renal transplant recipient: case report and literature review. Am. J. Ther.<\/i>, 23<\/b>, e614\u2013e616 (2016)."},{"key":"10","unstructured":"10) Su YC, Wu CC. Colchicine-induced acute neuromyopathy in a patient using concomitant fluconazole: case report and literature review. Drug Saf. Case Rep.<\/i>, 2<\/b>, 16 (2015)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Solomon LR. Thrombocytopenia due to low-dose colchicine therapy: A possible drug interaction with nivolumab and implications for supportive care. Acta Oncol.<\/i>, 54<\/b>, 1235\u20131237 (2015).","DOI":"10.3109\/0284186X.2014.1002572"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Davis MW, Wason S. Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions. Clin. Drug Investig.<\/i>, 34<\/b>, 259\u2013267 (2014).","DOI":"10.1007\/s40261-013-0168-8"},{"key":"13","unstructured":"13) Japan Medical Data Center. \u2039https:\/\/www.jmdc.co.jp\/en\/\u203a, accessed 20 December, 2019."},{"key":"14","unstructured":"14) TAKATA Pharmaceutical Co. Ltd. \u201cCOLCHICINE (colchicine) [package insert]. Pharmaceuticals and Medical Devices Agency website.\u201d: \u2039\u2009https:\/\/www.takata-seiyaku.co.jp\/medical\/product\/t_3944\/tb_t-3944.pdf\u203a, accessed 20 December, 2019."},{"key":"15","unstructured":"15) Takeda Pharmaceuticals USA. Inc. \u201cCOLCRYS (colchicine) [label]. U.S. Food and Drug Administration website.\u201d: \u2039https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/022352s022lbl.pdf\u203a, accessed 20 December, 2019."},{"key":"16","unstructured":"16) Narang RK, Dalbeth N. Management of complex gout in clinical practice: update on therapeutic approaches. Best Pract. Res. Clin. Rheumatol.<\/i>, 32<\/b>, 813\u2013834 (2018)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L. EULAR recommendations for the management of familial Mediterranean fever. Ann. Rheum. Dis.<\/i>, 75<\/b>, 644\u2013651 (2016).","DOI":"10.1136\/annrheumdis-2015-208690"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Lutschinger LL, Rigopoulos AG, Schlattmann P, Matiakis M, Sedding D, Schulze C, Noutsias M. Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome. BMC Cardiovasc. Disord.<\/i>, 19<\/b>, 207 (2019).","DOI":"10.1186\/s12872-019-1195-z"},{"key":"19","unstructured":"19) Saenz A, Ausejo M, Shea B, Wells GA, Welch V, Tugwell P. Pharmacotherapy for Behcet\u2019s syndrome. Cochrane Database Syst. Rev.<\/i>, 2<\/b>, CD001084 (2000)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Imai S, Momo K, Kashiwagi H, Miyai T, Sugawara M, Takekuma Y. Nonsteroidal anti-inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them. Pharmacoepidemiol. Drug Saf.<\/i>, 29<\/b>, 873\u2013880 (2020).","DOI":"10.1002\/pds.5027"},{"key":"21","unstructured":"21) Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, Tsuruya K, Iida M, Kiyohara Y. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: The Hisayama Study. Nephrol. Dial. Transplant.<\/i>, 25<\/b>, 2557\u20132564 (2010)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kim HY. Statistical notes for clinical researchers: Chi-squared test and Fisher\u2019s exact test. Restor. Dent. Endod.<\/i>, 42<\/b>, 152\u2013155 (2017).","DOI":"10.5395\/rde.2017.42.2.152"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Akoglu H. User\u2019s guide to correlation coefficients. Turk. J. Emerg. Med.<\/i>, 18<\/b>, 91\u201393 (2018).","DOI":"10.1016\/j.tjem.2018.08.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Terkeltaub RA, Furst DE, DiGiacinto JL, Kook KA, Davis MW. Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors. Arthritis Rheum.<\/i>, 63<\/b>, 2226\u20132237 (2011).","DOI":"10.1002\/art.30389"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tsutsui A, Yahara K, Shibayama K. Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. J. Infect. Chemother.<\/i>, 24<\/b>, 414\u2013421 (2018).","DOI":"10.1016\/j.jiac.2018.01.003"},{"key":"26","unstructured":"26) Mandell LA. Community-acquired pneumonia: an overview. Postgrad. Med.<\/i>, 127<\/b>, 607\u2013615 (2015)."},{"key":"27","unstructured":"27) Leung AKC, Barankin B, Leong KF. Staphylococcal-scalded skin syndrome: Evaluation, diagnosis, and management. World J. Pediatr.<\/i>, 14<\/b>, 116\u2013120 (2018)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, Craig WA. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol. Head Neck Surg.<\/i>, 130<\/b> (Suppl. 1), 1\u201345 (2004).","DOI":"10.1016\/j.otohns.2003.12.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Crowe SE. Helicobacter pylori<\/i> infection. N. Engl. J. Med.<\/i>, 380<\/b>, 1158\u20131165 (2019).","DOI":"10.1056\/NEJMcp1710945"},{"key":"30","unstructured":"30) Qaseem A, Harris RP, Forciea MA. Clinical guidelines committee of the american college of physicians. Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med.<\/i>, 166<\/b>, 58\u201368 (2017)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Richette P, Doherty M, Pascual E, et al.<\/i> 2016 Updated EULAR evidence-based recommendations for the management of gout. Ann. Rheum. Dis.<\/i>, 76<\/b>, 29\u201342 (2017).","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"32","unstructured":"32) Barry RJ, Markandey B, Malhotra R, Knott H, Joji N, Mubin M, Denniston AK, Murray PI. Evidence-based practice in Beh\u00e7et\u2019s disease: identifying areas of unmet need for 2014. Orphanet J. Rare Dis.<\/i>, 9<\/b>, 16 (2014)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K, Nagahori M, Arai K, Uchino M, Koganei K, Kobayashi T, Takeno M, Ueno F, Matsumoto T, Mizuki N, Suzuki Y, Hisamatsu T. Evidence-based diagnosis and clinical practice guidelines for intestinal Beh\u00e7et\u2019s disease 2020 edited by intractable diseases, the Health and Labour Sciences research grants. J. Gastroenterol.<\/i>, 55<\/b>, 679\u2013700 (2020).","DOI":"10.1007\/s00535-020-01690-y"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J. Epidemiol.<\/i>, 27<\/b>, 476\u2013482 (2017).","DOI":"10.1016\/j.je.2016.09.009"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol.<\/i>, 49<\/b>, 1373\u20131379 (1996).","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"36","unstructured":"36) Sato I, Akazawa M. Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Drug Healthc. Patient Saf.<\/i>, 5<\/b>, 143\u2013150 (2013)."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, Branch LC, Schmader KE. Unnecessary drug use in frail older people at hospital discharge. J. Am. Geriatr. Soc.<\/i>, 53<\/b>, 1518\u20131523 (2005).","DOI":"10.1111\/j.1532-5415.2005.53523.x"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/10\/43_b20-00314\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:13:22Z","timestamp":1601694802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/10\/43_b20-00314\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00314","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}